NEWS

News

November

09/11/2020

Philogen will be attending the PEGS Europe Virtual Conference from November 9 to 12, 2020.
Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Keynote Presentation in the Tumor Microenvironment Session (Immunotherapy Stream) on November 10 with the title: Immunocytokines with "Activity on Demand".
Prof. Dario Neri will also give a Lecture in the Antibody-Drug Conjugates Session (Oncology Stream) on November 10 with the title: Antibody-Drug Conjugates (ADCs) and Small-Molecule Drug Conjugates (SMDCs): A Comparative Analysis.
 

02/11/2020

Philochem will be attending the Festival of Biologics virtual conference from November 2nd to 6th, 2020.
Dr. Samuele Cazzamalli (Group Leader Small-Molecule Therapeutics) and Sheila Dakhel, (Associate Research Scientist) will give a lecture

02/11/2020

Philogen will be attending the Next Generation Protein Therapeutics & Bioconjugates Summit from November 2 to 5, 2020.
Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Keynote Lecture with the title: Cancer Therapy Using Antibody-Cytokine Fusion Proteins.
 

September

15/09/2020

Philogen will be attending the World ADC Digital Conference from September 15 to 18, 2020.
Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Plenary Lecture on: “Small Molecule-drug Conjugates (SMDCs) & ADCs: A Comparative Evaluation”.

July

17/07/2020

Philochem announces a publication entitled: “A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients”
Link to Paper

April

30/04/2020

Philochem announces a publication entitled: “On-DNA hit validation methodologies for ligands identified from DNA-encoded chemical libraries”
Link to Paper

28/04/2020

Philogen announces option excercise by Janssen

  PHILOGEN ANNOUNCES OPTION EXERCISE BY JANSSEN .pdf

March

31/03/2020

Philochem is happy to announce the start of an Innosuisse collaboration with the Department of Neurology at the University Hospital and University of Zurich. During the collaboration, both teams will explore the usage of novel Immunocytokines for the treatment of brain tumors in preclinical mouse models facilitating the development of novel brain tumor therapies.
 

February

15/02/2020

Philochem announces a publication entitled: “Critical Evaluation of Photo-cross-linking Parameters for the Implementation of Efficient DNA-Encoded Chemical Library Selections”
Link to Paper

01/02/2020

Philochem will be attending the 10th World ADC Conference in London (United Kingdom) from March 2 to 5, 2020
10th World ADC London
Dr. Samuele Cazzamalli will give a plenary lecture on: “Small Molecule-DrugConjugates: Getting small to enhance targeting”
Jacopo Millul will give a presentation on: “Encoded Self-Assembling Chemical Libraries for the Discovery of New Small Molecules for Tumour-Associated Antigens”

x

By continuing to browse or by closing this window, you accept the use of cookies.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. By closing this banner or continuing to browse, you agree to the use of cookies.

I Accept Cookie Policy
X